Reinfection, rather than persistent infection, in patients with chronic granulomatous disease

Journal of Infectious Diseases

Volumn 187, Issue 5, 2003, Pages 845-853

  Guide, Shireen V ^a,b,c,d   Stock, Frida ^b   Gill, Vee J ^b   Anderson, Victoria L ^a   Malech, Harry L ^a   Gallin, John I ^a   Holland, Steven M ^a,e  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c STANFORD UNIVERSITY   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e MSC 1886 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; GAMMA INTERFERON; ITRACONAZOLE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BIOCHEMISTRY; BURKHOLDERIA CEPACIA; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MICROORGANISM; PATIENT; PERSISTENT INFECTION; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RECURRENT INFECTION; REINFECTION; SCHOOL CHILD; SERRATIA MARCESCENS; SPECIES DIFFERENTIATION; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CHILD; ELECTROPHORESIS, GEL, PULSED-FIELD; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LIVER ABSCESS; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; RECURRENCE; SERRATIA INFECTIONS; SERRATIA MARCESCENS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0037334418     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368388     Document Type: Article

References (38)

1. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79:170-200.
2. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:155-69.
3. Kobayashi Y, Amano D, Ueda K, Kagosaki Y, Usui T. Treatment of seven cases of chronic granulomatous disease with sulfamethoxazoletrimethoprim (SMX-TMP). Eur J Pediatr 1978; 127:247-54.
4. Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. Arch Dis Child 1990; 65:942-5.
5. Petropoulou T, Liese J, Tintelnot K, Gahr M, Belohradsky BH. Long-term treatment of patients with itraconazole for the prevention of Aspergillus infections in patients with chronic granulomatous disease (CGD) [in German]. Mycoses 1994; 37:64-9.
6. Wendt C, Messer SA, Hollis RJ, Pfaller MA, Wenzel RP, Herwaldt LA. Molecular epidemiology of gram-negative bacteremia. Clin Infect Dis 1999; 28:605-10.
7. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
8. Bingen E, Bonacorsi S, Rohrlich P, et al. Molecular epidemiology provides evidence of genotypic heterogeneity of multidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital. J Clin Microbiol 1996; 34:3226-9.
9. Vandamme AM. Evolving viruses and virologists. The Fifth European Workshop on Virus Evolution and Molecular Epidemiology, Leuven, Belgium, 30 August to 4 September 1999. Trends Microbiol 2000; 8:8-10.
10. Traub WH, Eiden A, Leonhard B, Bauer D. Phenotypic variation of clinical Serratia marcescens isolates repeatedly recovered from individual patients. Zentralbl Bakteriol 1996; 284:124-35.
11. Rello J, Mariscal D, March F, et al. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med 1998; 157:912-6.
12. Niederman MS, Mantovani R, Schoch P, Papas J, Fein AM. Patterns and routes of tracheobronchial colonization in mechanically ventilated patients: the role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest 1989; 95:155-61.
13. Segonds C, Bingen E, Couetdic G, et al. Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol 1997; 35:2055-60.
14. LiPuma JJ, Fisher MC, Dasen SE, Mortensen JE, Stull TL. Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. J Infect Dis 1991; 164:133-6.
15. Branger C, Gardye C, Lambert-Zechovsky N. Persistence of Staphylococcus aureus strains among cystic fibrosis patients over extended periods of time. J Med Microbiol 1996; 45:294-301.
16. Steinbach S, Sun L, Jiang RZ, et al. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med 1994; 331:981-7.
17. Wallace RJ Jr, Zhang Y, Brown BA, et al. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med 1998; 158:1235-44.
18. Telles MA, Yates MD, Curcio M, et al. Molecular epidemiology of Mycobacterium avium complex isolated from patients with and without AIDS in Brazil and England. Epidemiol Infect 1999; 122:435-40.
19. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344:11-6.
20. Boelaert JR, Van Landuyt HW, Gordts BZ, De Baere YA, Messer SA, Herwaldt LA. Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: the effect of nasal mupirocin. Infect Control Hosp Epidemiol 1996; 17:809-11.
21. Luzar MA. Exit-site infection in continuous ambulatory peritoneal dialysis: a review. Perit Dial Int 1991; 11:333-40.
22. Kluytmans JA, Mouton JW, VandenBergh MF, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996; 17:780-5.
23. Ena J, Boelaert JR, Boyken LD, Van Landuyt HW, Godard CA, Herwaldt LA. Epidemiology of Staphylococcus aureus infections in patients on hemodialysis. Infect Control Hosp Epidemiol 1994; 15:78-81.
24. Wilcox MH, Fawley WN, Settle CD, Davidson A. Recurrence of symptoms in Clostridium difficile infection - relapse or reinfection? J Hosp Infect 1998; 38:93-100.
25. Johnson S, Adelmann A, Clabots CR, Peterson LR, Gerding DN. Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis 1989; 159:340-3.
26. O'Neill GL, Beaman MH, Riley TV. Relapse versus reinfection with Clostridium difficile. Epidemiol Infect 1991; 107:627-35.
27. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000; 38:2386-8.
28. van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341:1174-9.
29. Fowler VG Jr, Kong LK, Corey GR, et al. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 1999; 179:1157-61.
30. Hartstein AI, Mulligan ME, Morthland VH, Kwok RY. Recurrent Staphylococcus aureus bacteremia. J Clin Microbiol 1992; 30:670-4.
31. Hatakka M, Bjorkroth KJ, Asplund K, Maki-Petays N, Korkeala HJ. Genotypes and enterotoxicity of Staphylococcus aureus isolated from the hands and nasal cavities of flight-catering employees. J Food Prot 2000; 63:1487-91.
32. Villari P, Iacuzio L, Vozzella EA, Raia V, Torre I. The epidemiology of Burkholderia cepacia in cystic fibrosis patients: the initial results of a study including the genotypic typing of the strains isolated [in Italian]. Ann Ig 1999; 11:501-6.
33. Walter S, Gudowius P, Bosshammer J, et al. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis. Thorax 1997; 52:318-21.
34. Ledson MJ, Gallagher MJ, Corkill JE, Hart CA, Walshaw MJ. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 1998; 53:432-6.
35. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990; 336:1094-6.
36. Ojeniyi B, Frederiksen B, Hoiby N. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. Pediatr Pulmonol 2000; 29:177-81.
37. Smith DL, Gumery LB, Smith EG, Stableforth DE, Kaufmann ME, Pitt TL. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol 1993; 31:3017-22.
38. Gessner AR, Mortensen JE. Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Med Microbiol 1990; 33:115-20.